Hetero-vancomycin-intermediate methicillin-resistant Staphylococcus aureus isolate from a medical center in Las Graces, New Mexico

Journal of Clinical Microbiology

Volumn 45, Issue 4, 2007, Pages 1325-1329

  Delgado, Alejandro ^a   Riordan, James T ^a   Lamichhane Khadka, Reena ^a   Winnett, David C ^a   Jimenez, Jennifer ^b   Robinson, Kim ^c   O'Brien, Frances G ^d   Cantore, Stephanie A ^a   Gustafson, John E ^a  

^a NEW MEXICO STATE UNIVERSITY   (United States)

^b Mountain View Regional Medical Center   (United States)

^c Memorial Medical Center   (United States)

^d CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; METICILLIN; OXACILLIN; PSEUDOMONIC ACID; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; GENE; HEALTH SURVEY; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SPA GENE; STAPHYLOCOCCUS AUREUS; STRAIN IDENTIFICATION; UNITED STATES;

ANTI-BACTERIAL AGENTS; CLUSTER ANALYSIS; COLONY COUNT, MICROBIAL; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HOSPITALS; HUMANS; METHICILLIN RESISTANCE; MICROBIAL VIABILITY; NEW MEXICO; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEXAS; VANCOMYCIN RESISTANCE;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 34247179119     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02437-06     Document Type: Article

References (19)

1. Ariza, J., M. Pujol, J. Cabo, C. Pea, N. Fernandez, J. Linares, J. Ayats, and F. Gudiol. 1999. Vancomycin in surgical infections due to methicillin resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet 353:1587-1588.
2. Centers for Disease Control and Prevention. 2001. NNIS system: national nosocomial infections surveillance (NNIS) system report, data summary from January 1992-April 2001, issued August 2001. Am. J. Infect. Control 29:400-421.
3. Charles, P. G., P. B. Ward, P. D. Jobnson, B. P. Howden, and M. L. Grayson. 2004. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin. Infect. Dis. 38:448-451.
4. Enright, M. C., D. A. Robinson, G. Randle, E. J. Feil, H. Grundmann, and B. G. Spratt. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. USA 99:7687-7692.
5. Fridkin, S. K., J. Hageman, L. K. McDougal, J. Mohammed, W. R. Jarvis, T. M. Perl, F. C. Tenover, and the Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group. 2003. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin. Infect. Dis. 36:429-439.
6. Kazakova, S. V., J. C. Hageman, M. K. Matava, A. Srinivasan, L. Phelan, B. Garfinkel, T. Boo, S. McAllister, J. Anderson, B. Jensen, D. Dodson, D. Lonsway, L. McDougal, M. Arduino, V. J. Fraser, G. Killgore, F. C. Tenover, S. Cody, and D. B. Jernigan. 2005. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352: 468-475.
7. Koreen, L. S., S. V. Ramaswamy, E. A. Graviss, S. Naidich, J. M. Musser, and B. N. Krieswirth. 2004. spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J. Clin. Microbiol. 42:792-799.
8. McDougal, L. K., C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, and F. C. Tenover. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120.
9. Mitani, N., M. Ohnishi, T. Masutani, K. Murakawa, and Y. Okamoto. 2002. Molecular typing of methicillin-resistant Staphylococcus aureus by protein A gene sequencing. Jpn. J. Infect. Dis. 55:179-180.
10. Moran, G. J., A. Krisbnadasan, R. J. Gorwitz, G. E. Forshiem, L. K. McDougal, R. B. Carey, and D. A. Talan for the EMERGEny ID Net Study Group. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
11. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing. M100-S13. National Committee for Clinical Laboratory Standards, Wayne, PA.
12. O'Brien, F. G., T. T. Lim, D. C. Winnett, G. W. Coombs, J. C. Pearson, A. Delgado, M. J. Langevin, S. A. Cantore, L. Gonzalez, and J. E. Gustafson. 2005. Survey of El Paso methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43:2969-2972.
13. O'Leary, J. O., M. J. Langevin, C. T. D. Price, J. S. Blevins, M. S. Smeltzer, and J. E. Gustafson. 2004. Effects of sarA inactivation on intrinsic multidrug resistance mechanism of Staphylococcus aureus. FEMS Microbiol. Lett. 237: 297-302.
14. Roberts, R. B., A. de Lencastre, W. Eisner, E. P. Severina, B. Shopsin, B. N. Kreiswirth, A. Tomasz, and the MRSA Collaborative Study Group. 1998. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in twelve New York hospitals. J. Infect. Dis. 178:164-171.
15. Sieradzki, K., R. B. Roberts, S. W. Haber, and A. Tomasz. 1999. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340:517-523.
16. Soo Ko, K., K. R. Peck, W. Sup Oh, N. Y. Lee, K. Hiramatsu, and J. H. Song. 2005. Genetic differentiation of methicillin-resistant Staphylococcus aureus strains from Korea and Japan. Microb. Drug Resist. 11:279-286.
17. Tenover, F. C., L. K. McDougal, R. V. Goering, G. Killgore, S. J. Projan, J. B. Patel, and P. M. Dunman. 2006. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J. Clin. Microbiol. 44:2533-2540.
18. Woods, C. W., A. C. Cheng, V. G. Fowler, M. Moorefield, J. Frederick, G. Sakoulas, V. G. Meka, F. C. Tenover, P. Zwadyk, and K. H. Wilson. 2004. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. Clin. Infect. Dis. 38:1188-1191.
19. Wootton, M., T. R. Walsh, and A. P. MacGowan. 2005. Evidence for reduction in breakpoints used to determine vancomycin susceptibility in Staphylococcus aureus. Antimicrob. Agents Chemother. 49:3982-3983.